Pfizer's Exubera Inhaled Insulin To Be Reviewed By Endocrine Committee Sept. 8

Inhalation powder will be evaluated for diabetes mellitus in adults by FDA's Endocrinologic & Metabolic Drugs Advisory Committee. Developed in conjunction with Sanofi-Aventis, Exubera would be first inhaled insulin product.